Denied

No. 19-1058

Hospira, Inc. v. Eli Lilly and Company

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Reply of petitioner Hospira, Inc. filed. (Distributed)

DISTRIBUTED for Conference of 6/11/2020.

Motion to delay distribution of the petition for a writ certiorari until May 26, 2020, granted.

Motion of petitioner to delay distribution of the petition for a writ of certiorari under Rule 15.5 from May 12, 2020 to May 26, 2020, submitted to The Clerk.

Brief of respondents Eli Lilly and Company in opposition filed. VIDED.

Brief amicus curiae of America's Health Insurance Plans filed.

Brief amicus curiae of R Street Institute filed. VIDED

Motion to extend the time to file a response is granted and the time is extended to and including April 27, 2020.

Motion to extend the time to file a response from March 27, 2020 to April 27, 2020, submitted to The Clerk.

Petition for a writ of certiorari filed. (Response due March 27, 2020)

Application (19A841) granted by The Chief Justice extending the time to file until February 24, 2020.

Application (19A841) to extend the time to file a petition for a writ of certiorari from February 6, 2020 to February 24, 2020, submitted to The Chief Justice.

Parties

Hospira, Inc., Petitioner, represented by Adam G. Unikowsky

Eli Lilly and Company, Respondent, represented by Adam Lawrence Perlman

Amici Curiae

America's Health Insurance Plans, Amicus Curiae, represented by Anna-Rose Mathieson

R Street Institute, Amicus Curiae, represented by Charles Duan

 
Last updated: October 29, 2020